Open an account

APOLLO BioWellness

KOAN · OTC

$0.0005+$0.00 (+0.00%)TodayMarket closed ·
Prev close $0.0005

About KOAN

Resonate Blends, Inc. is a cannabis holding company, which engages in the provision of cannabis-based products. The company is headquartered in Calabasas, California. The firm is engaged in the field of regenerative medicine using biologic-based products. Its products are intended to market under third-party label exemptions. The firm is focused on marketing licensed patent-pending natural stem cell mobilizing agents capable of enhancing each individual's ability to mobilize their own adult stem cells from their bone marrow. The company is licensed under a patent-pending application to market a dual-acting all-natural diet aid designed to help control hunger through normal body signals to the brain and stomach. Its products are being developed for consumer and professional markets.

Employees
6
Headquarters
Calabasas, California
Listed
Mar 31, 1993
Sector
Health Care
Industry
Pharmaceuticals
Website
resonateblends.com

KOAN key statistics

Market cap
261.04K
Price-earnings ratio
0.00
Dividend yield
—
Average volume
5.73M
Volume
17.74M
Open price
$0.0004
High today
$0.0005
Low today
$0.0003
52 Week high
$0.0161
52 Week low
$0.0002

APOLLO BioWellness (KOAN) at a glance

APOLLO BioWellness (KOAN) last traded at $0.0005, with a market cap of 261.04K and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.0003 and $0.0005. The current price is 66.7% above the day's low and 0.0% below its high.

Volume so far is 17.74M shares, above the average of 5.73M shares a day.

Over the past year APOLLO BioWellness has ranged from $0.0002 to $0.0161, and now sits 2% of the way up that range.

APOLLO BioWellness met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q2 FY25 it reported $0.00 per share against an estimate of $0.00.

KOAN earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 8 quarters, by 2.0% on average.

  1. Q3 FY99: reported -$1,200.00 per share against an estimate of -$1,224.00
  2. Q1 FY00: reported -$2,100.00 per share against an estimate of -$2,142.00
  3. Q2 FY00: reported -$2,100.00 per share against an estimate of -$459.00
  4. Q3 FY00: reported -$1,200.00 per share against an estimate of $0.00
  5. Q1 FY03: reported $1,200.00 per share against an estimate of $1,632.00
  6. Q2 FY03: reported $200.00 per share against an estimate of $1,122.00
  7. Q1 FY24: reported -$0.01 per share against an estimate of $0.00
  8. Q2 FY25: reported $0.00 per share against an estimate of $0.00

Similar companies

Companies in the same industry as APOLLO BioWellness

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.